Docetaxel immunonanocarriers as targeted delivery systems for HER 2-positive tumor cells: preparation, characterization, and cytotoxicity studies

Mona Noori Koopaei1 Novel Drug Delivery Laboratory, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran

Rassoul Dinarvand1 Novel Drug Delivery Laboratory, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran;2 Nanotechnology Research Center, Tehran University of Medical Sciences, Tehran, IranCorrespondence[email protected]

Mohsen Amini3 Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran

Hojatollah Rabbani4 Monoclonal Antibody Research Center, Avesina Research Institute, ACECR, Tehran, Iran

Shaghayegh Emami4 Monoclonal Antibody Research Center, Avesina Research Institute, ACECR, Tehran, Iran

Seyed Nasser Ostad5 Department of Toxicology and Pharmacology, Faculty of Pharmacy, Tehran University of Medical Science, Tehran, Iran

Fatemeh Atyabi1 Novel Drug Delivery Laboratory, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran;2 Nanotechnology Research Center, Tehran University of Medical Sciences, Tehran, Iran

show all

Pages 1903-1912 | Published online: 08 Sep 2011

Cite this article

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

YokoyamaMDrug targeting with nano-size carrier systemsJ Artif Organs20058778416094510
PubMedGoogle Scholar
Cirstoiu-HapcaABucheggerFLangeNBenefit of anti- HER2- coated paclitaxel-loaded immuno-nanoparticles in the treatment of disseminated ovarian cancer: Therapeutic efficacy and biodistribution in miceJ Control Release201014432433120219607
PubMed Web of Science ®Google Scholar
ZhangLRadovic-MorenoAFAlexisFCo-delivery of hydrophobic and hydrophilic drugs from nanoparticle–aptamer bioconjugatesChemMedChem200721268127117600796
PubMed Web of Science ®Google Scholar
MishraBPatelBBTiwariSColloidal nanocarriers: A review on formulation technology, types and applications toward targeted drug deliveryNanomedicine2010692419447208
PubMed Web of Science ®Google Scholar
HarbeckNPegramMDRüschoffJMöbusVTargeted therapy in metastatic breast cancer: The HER2/neu oncogeneBreast Care (Basel)201053720847829
PubMed Web of Science ®Google Scholar
DinarvandRSepehriNManoochehriSRouhaniHAtyabiFPolylactide- co-glycolide nanoparticles for controlled delivery of anticancer agentsInt J Nanomedicine2011687789521720501
PubMed Web of Science ®Google Scholar
AcharyaSSahooSKPLGA nanoparticles containing various anticancer agents and tumor delivery by EPR effectAdv Drug Deliv Rev20116317018320965219
PubMed Web of Science ®Google Scholar
ManchandaRFernandez-FernandezANagesettiAMcGoronAJPreparation and characterization of a polymeric (PLGA) nanoparticulate drug delivery system with simultaneous incorporation of chemotherapeutic and thermo-optical agentsColloids Surf B Biointerfaces20107526026719775872
PubMed Web of Science ®Google Scholar
EghtedariMLiopoAVCoplandJAOraevskyAAMotamediMMEngineering of hetero-functional gold nanorods for the vivo molecular targeting of breast cancerNano Lett2009928729119072129
PubMed Web of Science ®Google Scholar
KocbekPObermajerNCegnarMKosJKristlJTargeting cancer cells using PLGA nanoparticles surface modified with monoclonal antibodyJ Control Release2007120182617509712
PubMed Web of Science ®Google Scholar
NobsLBucheggerFGurnyRAllémannECurrent methods for attaching targeting ligands to liposomes and nanoparticlesJ Pharm Sci2004931980199215236448
PubMed Web of Science ®Google Scholar
AnhornMGWagnerSKreuterJLangerKvon BriesenHSpecific targeting of HER2 overexpressing breast cancer cells with doxorubicin-loaded trastuzumab-modified human serum albumin nanoparticlesBioconjug Chem2008192321233118937508
PubMed Web of Science ®Google Scholar
EsmaeiliFGhahremaniMHOstadSNFolate-receptor-targeted delivery of docetaxel nanoparticles prepared by PLGA-PEG-folate conjugateJ Drug Target20081641542318569286
PubMed Web of Science ®Google Scholar
EsmaeiliFDinarvandRGhahremaniMHDocetaxel-albumin conjugates: Preparation, in vitro evaluation and biodistribution studiesJ Pharm Sci2009982718273018972321
PubMed Web of Science ®Google Scholar
YousefiAEsmaeiliFRahimianSAtyabiFDinarvandFPreparation and in vitro evaluation of a pegylated nano-liposomal formulation containing docetaxelSci Pharm200977453464
Google Scholar
EsmaeiliFDinarvandRGhahremaniMHOstadSNEsmailyHAtyabiFCellular cytotoxicity and in-vivo biodistribution of docetaxel poly (lactide-co-glycolide) nanoparticlesAnticancer Drugs201021435219809300
PubMed Web of Science ®Google Scholar
SaremiSHAtyabiFAkhlaghiSPOstadSNDinarvandRThiolated chitosan nanoparticles for enhancing oral absorption of docetaxel: Preparation, in vitro and ex vivo evaluationInt J Nanomedicine2011611912821289989
PubMed Web of Science ®Google Scholar
Cirstoiu-HapcaABossy-NobsLBucheggerFGurnyRDelieFDifferential tumor cell targeting of anti-HER2 (Herceptin) and anti- CD20 (Mabthera) coupled nanoparticlesInt J Pharm200733119019617196347
PubMed Web of Science ®Google Scholar
MilaneLDuanZFAmijiMPharmacokinetics and biodistribution of lonidamine/paclitaxel loaded, EGFR-targeted nanoparticles in an orthotopic animal model of multi-drug resistant breast cancerNanomedicine182011 [Epub ahead of print.]
Web of Science ®Google Scholar
EbrahimnejadPDinarvandRNomaniARAziziEPreparation and in vitro evaluation of actively targetable nanoparticles for SN-38 delivery against HT-29 cell linesNanomedicine2010647848519836467
PubMed Web of Science ®Google Scholar
GanCWFengSSTransferrin-conjugated nanoparticles of poly(lactide)-D-alpha-tocopheryl polyethylene glycol succinate diblock copolymer for targeted drug delivery across the blood-brain barrierBiomaterials2010317748775720673685
PubMed Web of Science ®Google Scholar
SteinhauserISpaBStrebhardtKLangerKTrastuzumab-modified nanoparticles: Optimisation of preparation and uptake in cancer cellsAnalysis20062749754983
Google Scholar
HobbsSKMonskyWLYuanFRegulation of transport pathways in tumor vessels: Role of tumor type and microenvironmentProc Natl Acad Sci U S A199895460746129539785
PubMed Web of Science ®Google Scholar
IshidaOMaruyamaKSasakiKIwatsuruMSize-dependent extravasation and interstitial localization of polyethyleneglycol liposomes in solid tumor-bearing miceInt J Pharm1999190495610528096
PubMed Web of Science ®Google Scholar
EsmaeiliFAtyabiFDinarvandRPreparation and characterization of estradiol-loaded PLGA nanoparticles using homogenization-solvent diffusion methodDaru200816196202
Web of Science ®Google Scholar
ChittasuphoCXieS-XBaoumAICAM-1 targeting of doxorubicin-loaded PLGA nanoparticles to lung epithelial cellsEur J Pharm Sci20093714115019429421
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Docetaxel immunonanocarriers as targeted delivery systems for HER 2-positive tumor cells: preparation, characterization, and cytotoxicity studies

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Docetaxel immunonanocarriers as targeted delivery systems for HER 2-positive tumor cells: preparation, characterization, and cytotoxicity studies

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date